Skip to main content
. 2022 Oct 13;15(11):1212–1224. doi: 10.1016/j.jiph.2022.10.006

Fig. 5.

Fig. 5

(A) The transmission of SARS-CoV-2 variants in children and the shadow pandemic on children caused by COVID-19; the immunogenicity, safety of (B) CoronaVac and (C) BNT162b2 in clinical trials.